Correction to: Effect of Bacillus clausii Capsules in Reducing Adverse Effects Associated with Helicobacter pylori Eradication Therapy: A Randomized, Double-Blind, Controlled Trial.

In the original publication, the Second author name was incorrectly published as Marcos Perez III.

Effect of Bacillus clausii Capsules in Reducing Adverse Effects Associated with Helicobacter pylori Eradication Therapy: A Randomized, Double-Blind, Controlled Trial.

Introduction: Antibiotic treatment can alter the gut microbiome and cause short-term gastrointestinal adverse effects (AEs). This study assessed the efficacy of lyophilized capsules containing 2 × 10 spores of Bacillus clausii (Enterogermina; Sanofi Synthelabo) in reducing AEs associated with Helicobacter pylori eradication therapy in Italy.

Methods: In this randomized, double-blind, single-center, phase IIIB study, 130 adult outpatients with H.